PharmD Capital Trading with PharmD_KS

PharmD Capital Trading with PharmD_KS

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 4/14

Market Analysis and Trades for 4/14

PharmD_KS's avatar
PharmD_KS
Apr 13, 2025
∙ Paid
11

Share this post

PharmD Capital Trading with PharmD_KS
PharmD Capital Trading with PharmD_KS
Market Analysis and Trades for 4/14
Share

If you are looking to join the Discord (now separate from the newsletter) please see here: JOIN THE DISCORD Please email help@pharmdcapital.com if there are any technical issues. Plans/levels will be posted in the Discord so there is no reason to subscribe to both.

The weekly post and for SPY 0.00%↑ and QQQ 0.00%↑ should be reviewed prior to this. Link to Market Analysis for The Week Ahead

SPY 0.00%↑

While NQ tagged its 7% down limit on Thursday, it actually left potential for a rather bullish weekly profile which had me interested in the long side if it (and bonds) cooperated on Friday. From Thursday night:

I was looking for NQ to build additional volume above 18248.75-18303 and then look to buy dips that held that spot or a quick look below and fail (LBAF). If it could then sustain above 18601-18630 it was likely to retest Thursday’s high:

We can see that the overnight session during Asia traded below 18248 but was quickly snapped up for a LBAF. It built volume above 18303 all night, came down and tested the range at the IB low which made the setup even better (a LBAF of the IB low is yet another reason to get long). The LBAF was quick and ferocious. NQ ultimately cleared 18601-18630, bid it from above, and resolved precisely to Thursday’s high.

This indeed ended up leaving NQ with a rather bullish weekly profile. The news has now come later as over the weekend Trump provided some exemptions from reciprocal tariffs that specifically benefits . . . big tech.

Will there be a gap up, and will such a gap be sustained?

Paid Content Below

PharmD Capital Trading with PharmD_KS is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Keep reading with a 7-day free trial

Subscribe to PharmD Capital Trading with PharmD_KS to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 PharmD_KS
Market data by Intrinio
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share